USPTO 2015–2025 USPTO PatentsView US Corporation

Asensus Surgical US, Inc.

USPTO PatentsView assignee record - 58 granted patents across 12 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

RSS updates for this company

The verdict

According to USPTO PatentsView, Asensus ranks #5,819 of 49,997 tracked US assignees by granted-patent volume, with 58 patents across 12 technology areas.

#5,819
of 49,997 US assignees by volume
Top 8%
by Innovation Score (53.9/100)
12.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R5819 · US Corporation #5,819 · 58 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 58 grants
  • UPPER-Q #5,819/49,997
  • PHOTO-FINISH Alpha and Omega…
  • CPC-FOCUS A61B · 12 areas
  • INNOV-PAR 53.9/100
  • CLAIMS-RICH 12.6 claims/avg
  • TYPE-USCORP US Corporation
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Alpha and Omega Semiconductor International LP (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Asensus’s 53.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Asensus

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Asensus's Innovation Score is 53.9/100 (top 8% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Asensus?

Each dot is one of Asensus’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Asensus’s own 12.6 claims/patent is at or below the 18.5 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Asensus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 57.958.058.05858.058.058.1 510152025 Granted patents (volume) Avg claims / patent Avigilon Fortress Corporation - 58, 21.14Avigilon FortressAlpha and Omega Semiconductor International LP - 58, 16.9Alpha and Omega S…Amphipod, Inc. - 58, 7.33AmphipodAndis Company - 58, 8.91AndisAyDeeKay LLC - 58, 19.38AydeekayBerg Companies, Inc. - 58, 22.59Berg CompaniesCerence Operating Company - 58, 18.97Cerence OperatingCollateral Opportunities, LLC - 58, 18.5Collateral Opport…Asensus Surgical US, Inc. - 58, 12.64Asensus Surgical…
Asensus vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Asensus's grants concentrate

Asensus Surgical US, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2023 (16 grants) versus a trough of 7 in 2021. By volume, Asensus sits between Avigilon Fortress Corporation and Collateral Opportunities, LLC.

Asensus's three-year grant acceleration

Asensus Surgical US, Inc. shows 41 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Asensus's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Asensus holds 58 patents at rank #5,821, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Asensus

By rank, the assignees closest to #5,821 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Asensus's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Asensus, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Asensus ranks #320 of 7,127 assignees by patent count in that subclass.

Asensus's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

54 Top 8% higher than 92% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

681012141618 20212022202320242025 10
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Asensus Surgical US, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 7 12.1%
2022 9 15.5%
2023 16 27.6%
2024 16 27.6%
2025partial year 10 17.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Asensus Surgical US, Inc.'s patent record in context - here's where to go next.

  • Asensus Surgical US, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
  • Ranked #5,819 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Asensus Surgical US, Inc. against Avigilon Fortress Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 53.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.